In-depth guide

UPDATED FEB 2026

Part of the IVC Filter investigation

The short answer

The FDA warned in 2010 and again in 2014 that retrievable IVC filters posed serious risks when left in place long-term. Post-market 522 studies ordered in 2015 to 2016 confirmed high fracture and perforation rates.

No recall was ever issued — but FDA warnings are powerful evidence of manufacturer knowledge in IVC filter lawsuits.

People's Justice Research TeamUpdated February 23, 2026Fact-checked

Verified against court and regulatory records · No upfront fees · Your information is never sold

Free Case Review

Check your eligibility — free

Answer 2-3 quick questions to review your potential case.

Free · Confidential · About 2 minutes · A case specialist responds within 1 business day

Your answers are never sold or shared without your consent.

The FDA's 2010 and 2014 safety communications are central to IVC filter litigation. Plaintiffs argue that these warnings — combined with the internal documents produced in MDL discovery — establish that Bard and Cook knew or should have known of the serious fracture and migration risks years before adequately warning physicians or patients. The FDA's 522 post-market study orders and results provide additional independent evidence of defect rates and manufacturer knowledge.

The full investigation

Part of the IVC Filter Investigation